Report
Louis-Clément AZAIS d'UHART
EUR 112.46 For Business Accounts Only

Short term view - SMITH & NEPHEW PLC : The major support has been breached.

Our previous opinion was neutral.
We turn negative with a target at 1101 p and an invalidation level at 1213 p.
The bullish trend may be reversing to bearish.
Arguments :
- The major support has been breached.
- Prices are breaking below the moving average, it is a sign of...
Underlying
SMITH & NEPHEW PLC

Smith & Nephew is a global medical devices business operating in the markets for advanced surgical devices comprising orthopaedic reconstruction and trauma, sports medicine and advanced wound management. Co.'s advanced medical products and services include: Orthopaedic Reconstruction and Trauma (joint replacement systems for knees and hips and products to help repair broken bones); Advanced Wound Management (treatment and prevention products for hard-to-heal wounds); and Sports Medicine (implants and enabling technologies for minimally invasive repair of the joint).

Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Louis-Clément AZAIS d'UHART

Other Reports on these Companies
Other Reports from Day By Day

ResearchPool Subscriptions

Get the most out of your insights

Get in touch